According to the new research report published by Precedence Research, titled “Peptide Therapeutics Market (By Application: Gastrointestinal Disorder, Metabolic Disorder, Neurological Disorder, Cancer; By Type: Generic, Innovative; By Route of Administration: Oral, Parenteral, Pulmonary, Mucosal; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Drug Stores; By Synthesis Technology: Solid Phase Peptide Synthesis, Liquid Phase Peptide Synthesis, Hybrid Technology) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032 (By Product: Traditional, Advanced; By Application: Pottery, Tiles, Abrasives, Sanitary wave, Bricks & pipes, Others; By End User: Medical, Industrial, Building & Construction, Others) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032”, the global peptide therapeutics market size is expected to be worth around US$ 76.83 billion by 2032 and is poised to record a yearly growth rate of 5.94% from 2023 to 2032. The study investigates several elements and their consequences on the growth of the all-wheel drive market.
This report focuses on peptide therapeutics market volume and value at the global level, regional level and company level. From a global perspective, this report represents the overall peptide therapeutics market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, the Middle East & Africa, Latin America, etc.
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2032. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2548
The study also provides important advancements in organic and inorganic growth strategies in the worldwide peptide therapeutics market. A lot of corporations are prioritizing new launches, product approvals, and other business expansion techniques. In addition, the report offers profiles of peptide therapeutics market firms and market strategies. Furthermore, the research focuses on top industry participants, providing information such as company profiles, components and services offered, recent financial data, and key developments.
Peptide Therapeutics Market Report Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 45.67 Billion |
| Market Size by 2032 | USD 76.83 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 5.94% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Application, By Type, By Route of Administration, By Distribution Channel and By Synthesis Technology |
Also read: Uninterruptible Power Supply (UPS) Market Size to Worth US$ 13.16 Billion By 2032
Market Key Players
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the peptide therapeutics market.
Some of the prominent players in the peptide therapeutics market include
- Eli Lilly & Company
- Amgen Inc.
- Pfizer, Inc.
- Ever Neuro Pharma GmbH
- Bausch Health
- Abbvie
Peptide Therapeutics Market Segmentations
By Application
- Gastrointestinal Disorder
- Metabolic Disorder
- Neurological Disorder
- Cancer
- Others
By Type
- Generic
- Innovative
By Route of Administration
- Oral
- Parenteral
- Pulmonary
- Mucosal
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Drug Stores
By Synthesis Technology
- Solid Phase peptide Synthesis (SPPS)
- Liquid Phase Peptide Synthesis (LPPS)
- Hybrid Technology
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- The Middle East and Africa
Report Objectives
- To define, segment, and project the global market size for peptide therapeutics market
- To understand the structure of the market by identifying its various sub-segments
- To provide detailed information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To analyse the micro-markets, with respect to individual growth trends, future prospects, and their contributions to the total market
- To project the size of the market and its submarkets, in terms of value, with respect to global. (along with their respective key countries)
- To profile key players and comprehensively analyse their core competencies
- To understand the competitive landscape and identify major growth strategies adopted by players across the globe.
- To analyse the competitive developments such as expansions & investments, new product launches, mergers & acquisitions, joint ventures, and agreements
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Peptide Therapeutics Market
5.1. COVID-19 Landscape: Peptide Therapeutics Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Peptide Therapeutics Market, By Application
8.1. Peptide Therapeutics Market, by Application, 2023-2032
8.1.1. Gastrointestinal Disorder
8.1.1.1. Market Revenue and Forecast (2023-2032)
8.1.2. Metabolic Disorder
8.1.2.1. Market Revenue and Forecast (2023-2032)
8.1.3. Neurological Disorder
8.1.3.1. Market Revenue and Forecast (2023-2032)
8.1.4. Cancer
8.1.4.1. Market Revenue and Forecast (2023-2032)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2023-2032)
Chapter 9. Global Peptide Therapeutics Market, By Type
9.1. Peptide Therapeutics Market, by Type, 2023-2032
9.1.1. Generic
9.1.1.1. Market Revenue and Forecast (2023-2032)
9.1.2. Innovative
9.1.2.1. Market Revenue and Forecast (2023-2032)
Chapter 10. Global Peptide Therapeutics Market, By Route of Administration
10.1. Peptide Therapeutics Market, by Route of Administration, 2023-2032
10.1.1. Oral
10.1.1.1. Market Revenue and Forecast (2023-2032)
10.1.2. Parenteral
10.1.2.1. Market Revenue and Forecast (2023-2032)
10.1.3. Pulmonary
10.1.3.1. Market Revenue and Forecast (2023-2032)
10.1.4. Mucosal
10.1.4.1. Market Revenue and Forecast (2023-2032)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2023-2032)
Chapter 11. Global Peptide Therapeutics Market, By Distribution Channel
11.1. Peptide Therapeutics Market, by Distribution Channel, 2023-2032
11.1.1. Hospital Pharmacies
11.1.1.1. Market Revenue and Forecast (2023-2032)
11.1.2. Retail Pharmacies
11.1.2.1. Market Revenue and Forecast (2023-2032)
11.1.3. Online Drug Stores
11.1.3.1. Market Revenue and Forecast (2023-2032)
Chapter 12. Global Peptide Therapeutics Market, By Synthesis Technology
12.1. Peptide Therapeutics Market, by Synthesis Technology, 2023-2032
12.1.1. Solid Phase peptide Synthesis (SPPS)
12.1.1.1. Market Revenue and Forecast (2023-2032)
12.1.2. Liquid Phase Peptide Synthesis (LPPS)
12.1.2.1. Market Revenue and Forecast (2023-2032)
12.1.3. Hybrid Technology
12.1.3.1. Market Revenue and Forecast (2023-2032)
Chapter 13. Global Peptide Therapeutics Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Application (2023-2032)
13.1.2. Market Revenue and Forecast, by Type (2023-2032)
13.1.3. Market Revenue and Forecast, by Route of Administration (2023-2032)
13.1.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)
13.1.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Application (2023-2032)
13.1.6.2. Market Revenue and Forecast, by Type (2023-2032)
13.1.6.3. Market Revenue and Forecast, by Route of Administration (2023-2032)
13.1.6.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)
13.1.6.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Application (2023-2032)
13.1.7.2. Market Revenue and Forecast, by Type (2023-2032)
13.1.7.3. Market Revenue and Forecast, by Route of Administration (2023-2032)
13.1.7.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)
13.1.7.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Application (2023-2032)
13.2.2. Market Revenue and Forecast, by Type (2023-2032)
13.2.3. Market Revenue and Forecast, by Route of Administration (2023-2032)
13.2.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)
13.2.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Application (2023-2032)
13.2.6.2. Market Revenue and Forecast, by Type (2023-2032)
13.2.6.3. Market Revenue and Forecast, by Route of Administration (2023-2032)
13.2.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
13.2.8. Market Revenue and Forecast, by Synthesis Technology (2023-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Application (2023-2032)
13.2.9.2. Market Revenue and Forecast, by Type (2023-2032)
13.2.9.3. Market Revenue and Forecast, by Route of Administration (2023-2032)
13.2.10. Market Revenue and Forecast, by Distribution Channel (2023-2032)
13.2.11. Market Revenue and Forecast, by Synthesis Technology (2023-2032)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Application (2023-2032)
13.2.12.2. Market Revenue and Forecast, by Type (2023-2032)
13.2.12.3. Market Revenue and Forecast, by Route of Administration (2023-2032)
13.2.12.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)
13.2.13. Market Revenue and Forecast, by Synthesis Technology (2023-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Application (2023-2032)
13.2.14.2. Market Revenue and Forecast, by Type (2023-2032)
13.2.14.3. Market Revenue and Forecast, by Route of Administration (2023-2032)
13.2.14.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)
13.2.15. Market Revenue and Forecast, by Synthesis Technology (2023-2032)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Application (2023-2032)
13.3.2. Market Revenue and Forecast, by Type (2023-2032)
13.3.3. Market Revenue and Forecast, by Route of Administration (2023-2032)
13.3.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)
13.3.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Application (2023-2032)
13.3.6.2. Market Revenue and Forecast, by Type (2023-2032)
13.3.6.3. Market Revenue and Forecast, by Route of Administration (2023-2032)
13.3.6.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)
13.3.7. Market Revenue and Forecast, by Synthesis Technology (2023-2032)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Application (2023-2032)
13.3.8.2. Market Revenue and Forecast, by Type (2023-2032)
13.3.8.3. Market Revenue and Forecast, by Route of Administration (2023-2032)
13.3.8.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)
13.3.9. Market Revenue and Forecast, by Synthesis Technology (2023-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Application (2023-2032)
13.3.10.2. Market Revenue and Forecast, by Type (2023-2032)
13.3.10.3. Market Revenue and Forecast, by Route of Administration (2023-2032)
13.3.10.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)
13.3.10.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Application (2023-2032)
13.3.11.2. Market Revenue and Forecast, by Type (2023-2032)
13.3.11.3. Market Revenue and Forecast, by Route of Administration (2023-2032)
13.3.11.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)
13.3.11.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Application (2023-2032)
13.4.2. Market Revenue and Forecast, by Type (2023-2032)
13.4.3. Market Revenue and Forecast, by Route of Administration (2023-2032)
13.4.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)
13.4.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Application (2023-2032)
13.4.6.2. Market Revenue and Forecast, by Type (2023-2032)
13.4.6.3. Market Revenue and Forecast, by Route of Administration (2023-2032)
13.4.6.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)
13.4.7. Market Revenue and Forecast, by Synthesis Technology (2023-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Application (2023-2032)
13.4.8.2. Market Revenue and Forecast, by Type (2023-2032)
13.4.8.3. Market Revenue and Forecast, by Route of Administration (2023-2032)
13.4.8.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)
13.4.9. Market Revenue and Forecast, by Synthesis Technology (2023-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Application (2023-2032)
13.4.10.2. Market Revenue and Forecast, by Type (2023-2032)
13.4.10.3. Market Revenue and Forecast, by Route of Administration (2023-2032)
13.4.10.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)
13.4.10.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Application (2023-2032)
13.4.11.2. Market Revenue and Forecast, by Type (2023-2032)
13.4.11.3. Market Revenue and Forecast, by Route of Administration (2023-2032)
13.4.11.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)
13.4.11.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Application (2023-2032)
13.5.2. Market Revenue and Forecast, by Type (2023-2032)
13.5.3. Market Revenue and Forecast, by Route of Administration (2023-2032)
13.5.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)
13.5.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Application (2023-2032)
13.5.6.2. Market Revenue and Forecast, by Type (2023-2032)
13.5.6.3. Market Revenue and Forecast, by Route of Administration (2023-2032)
13.5.6.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)
13.5.7. Market Revenue and Forecast, by Synthesis Technology (2023-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Application (2023-2032)
13.5.8.2. Market Revenue and Forecast, by Type (2023-2032)
13.5.8.3. Market Revenue and Forecast, by Route of Administration (2023-2032)
13.5.8.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)
13.5.8.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)
Chapter 14. Company Profiles
14.1. Eli Lilly & Company
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Amgen Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Pfizer, Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Ever Neuro Pharma GmbH
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Bausch Health
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Abbvie
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global peptide therapeutics market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for peptide therapeutics are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2023-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
